Christina Yau

18PUBLICATIONS
156CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 09, 2025
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.

Mark Jesus M Magbanua, Nayelis A Manon, Denise M Wolf

|Oct 25, 2025
Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial.

Oscar Danielsson, Huma Dar, Gizeh Perez-Tenorio

|Sep 04, 2025
Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer.

Emmanuel F Petricoin, Denise M Wolf, Christina Yau

|Jul 02, 2025
Insights from a multi-institutional registry show duration of endocrine treatment for DCIS impacts second events.

Thomas J O'Keefe, Christina Yau, Emma Iaconetti

|Jun 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.

Denise M Wolf, Christina Yau, Michael Campbell

|Feb 13, 2025
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer.

Rita A Mukhtar, Soumya Gottipati, Christina Yau

Pageof 3

Frequent Collaborators

14 joint publications

Laura J Esserman

11 joint publications

Gillian L Hirst

11 joint publications

Laura Van't Veer

8 joint publications

Lamorna Brown-Swigart